Allogeneic hematopoietic stem cell transplantation in Hodgkin lymphoma: a … – Nature.com
|
Allogeneic hematopoietic stem cell transplantation in Hodgkin lymphoma: a …
Nature.com Allogeneic stem cell transplantation (allo-SCT) outcomes in patients with Hodgkin lymphoma (HL) remain poorly defined. We performed a meta-analysis of allo-SCT studies in HL patients. The primary endpoints were 6-month, 1-year, 2-year and 3-year … |
